UNICHEMLABNSEUnichem Laboratories Limited· PharmaceuticalsMediumNeutral
Announced Fri, 10 Apr · 10:41 IST

Unichem Laboratories Limited has informed the Exchange about Credit Rating

Credit & Debt View source PDF

UNICHEMLAB · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-0.1%1-day move
₹337.00
prior close
₹343.00
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.3+0.1+2.0+1.7-0.1+3.0+3.7+3.8+2.8+9.8+11.0+12.2+35.2+88.6
Up moveDown movePending
AI summary

ICRA has reaffirmed its credit rating of [ICRA] A+ with a Stable outlook on Unichem Laboratories' Rs. 180 crore bank facilities. The rating covers Rs. 120 crore in long-term fund-based and non-fund based facilities, plus Rs. 60 crore in long-term unallocated limits. The rating action was communicated by ICRA to the company on April 9, 2026, and disclosed to the exchanges on April 10, 2026. A reaffirmation means ICRA sees no change in the company's creditworthiness compared to the previous assessment. The rating is due for surveillance review within one year.

Likely market impact

This is a neutral-to-positive signal for shareholders — the A+ rating with Stable outlook reflects continued confidence in the company's debt-servicing ability and financial health. No negative implications for the stock or borrowing costs at this time.